An RXR ligand
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

LG 100754

Item No. 19647

Technical Information
Formal Name
3-methyl-7-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-3-propoxy-2-naphthalenyl)-2E,4E,6Z-octatrienoic acid
CAS Number
180713-37-5
Synonyms
  • CD3159
  • LGD 100754
  • UVI2112
Molecular Formula
C26H36O3
Formula Weight
Purity
≥98%
Formulation
A crystalline solid
DMF: 30 mg/mlDMF:PBS (pH 7.2)(1:3): 0.25 mg/mlDMSO: 20 mg/mlEthanol: 5 mg/ml
λmax
246, 256, 318 nm
SMILES
CC1(C)C2=C(C=C(/C(C)=C\C=C\C(C)=C\C(O)=O)C(OCCC)=C2)C(C)(C)CC1
InChi Code
InChI=1S/C26H36O3/c1-8-14-29-23-17-22-21(25(4,5)12-13-26(22,6)7)16-20(23)19(3)11-9-10-18(2)15-24(27)28/h9-11,15-17H,8,12-14H2,1-7H3,(H,27,28)/b10-9+,18-15+,19-11-
InChi Key
HNODNXQAYXJFMQ-LQUSFLDPSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Cayman Chemical
    Explore Obesity & Metabolic Disease Resources

    Discover high-quality research tools to investigate GLP-1 mechanisms and next-generation metabolic targets.

    OBESITY RESEARCH SOLUTIONS
    Product Description

    LG 100754 is a ligand of retinoid X receptor (RXR) that modulates the activity of RXR dimers. It acts as an antagonist towards RXR homodimers but as an agonist of heterodimers consisting of RXR and retinoic acid receptor (RAR) or PPARs.1,2,3 LG 100754, at 1 µM, is a weak agonist of RXR-PPARγ but strongly enhances signaling through the heterodimer in response to PPARγ ligands, including rosiglitazone (Item No. 71740) and 15-deoxy-Δ12,14-prostaglandin J2 (Item No. 18570).4 Through this action, LG 100754 decreases glucose levels and relieves insulin resistance in mice.5,4

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Hida, T., Tai, K., Tokuhara, N., et alExistence of retinoic acid-receptor-independent retinoid X-receptor-dependent pathway in myeloid cell function. Jpn. J. Pharmacol. 85(1), 60-69 (2001).

    2. Lala, D.S., Mukherjee, R., Schulman, I.G., et alActivation of specific RXR heterodimers by an antagonist of RXR homodimers. Nature 383(6599), 450-453 (1996).

    3. Schulman, I.G., Li, C., Schwabe, J.W.R., et alThe phantom ligand effect: Allosteric control of transcription by the retinoid X receptor. Genes Dev. 11(3), 299-308 (1997).

    4. Forman, B.M. The antidiabetic agent LG100754 sensitizes cells to low concentrations of peroxisome proliferator-activated receptor gamma ligands. The Journal of Biological Chemisty 277(15), 12503-12506 (2002).

    5. Cesario, R.M., Klausing, K., Razzaghi, H., et alThe rexinoid LG100754 is a novel RXR:PPARγ agonist and decreases glucose levels in vivo. Mol. Endocrinol. 15(8), 1360-1369 (2001).